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Abstract
We describe an autopsy case of non-functioning pancreatic neuroendocrine carcinoma
metastasizing to the myocardium. A 63-year-old Japanese man was admitted to the hospital
presenting with dyspnea. Echocardiography revealed marked left ventricular hypertrophy and
diffuse myocardial thickening with pericardial effusion. The patient died of heart failure. An autopsy
revealed that the whole pancreas, weighing 400 g, was occupied by tumor cells with
neuroendocrine differentiation. The heart, weighing 780 g, showed numerous metastatic nodules
and diffuse myocardial thickening. Histopathologically, the tumor was diagnosed as non-functioning
pancreatic neuroendocrine carcinoma. Immunohistochemical analysis for D2-40 disclosed severe
lymphatic infiltration of tumor cells, characterized by diffuse thickening of the myocardium.
Introduction
Pancreatic neuroendocrine tumors are rare neoplasms
accounting for less than 5% of all primary pancreatic
malignancies [1]. Non-functioning pancreatic neuroen-
docrine tumors demonstrate endocrine differentiation
but lack a clinical syndrome of hormone hypersecretion.
Presentation is related to the mass effect of the tumor, and
patients can present with advanced metastatic disease but
relatively few symptoms [1]. Here, an autopsy case of non-
functioning pancreatic neuroendocrine carcinoma metas-
tasizing to the myocardium is reported.
Case presentation
A 63-year-old Japanese man was admitted to our hospital
complaining of dyspnea. He had a history of smoking (30
cigarettes a day for 40 years) and had been diagnosed as
hypertensive in the past. Echocardiography revealed
marked left ventricular hypertrophy and diffuse myocar-
dial thickening with pericardial effusion, simulating
hypertrophic cardiomyopathy. Computed tomography
(CT) revealed multiple lymphadenosis of the superior
mediastinum, the neck and the hilum of the lung. Biop-
sies of cervical lymph nodes and the pericardium revealed
metastatic neuroendocrine tumor suggestive of pancre-
atic, digestive tract, or lung origin. A cytologic examina-
tion from pericardial effusion was negative for
malignancy. Although the primary site was not identified,
the tumor was diagnosed as metastatic atypical carcinoid.
After two courses of anticancer chemotherapy (carbopla-
tin, irinotecan), the patient underwent radiation therapy.
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In spite of the intensive treatment, severe heart failure and
anemia developed gradually. The patient died of heart
failure, and an autopsy was conducted to disclose the ori-
gin of the cancer and the nature of the systemic disease,
including cardiac muscle lesions.
Pathologic Findings
Grossly, the whole pancreas, weighing 400 g, was occu-
pied by a tumor (Fig. 1AB) of cells with a characteristic
nested or trabecular growth pattern suggesting neuroen-
docrine differentiation (Fig. 2A). Immunohistochemi-
cally, the tumor cells were positive for major
neuroendocrine markers, such as synaptophysin, NCAM
(CD56), and chromogranin A (Fig. 2BCD). On the other
hand, the heart weighed 780 g and showed numerous
metastatic nodules and diffuse myocardial thickening
(Fig. 3A). Metastatic tumor cells invaded the myocardium
with stromal edema (Fig. 3B). Moreover, immunohisto-
chemical analysis for D2-40 demonstrated severe lym-
phatic infiltration of tumor cells (Fig. 3C). Aggressive
metastasis was confirmed at various loci including the
liver, lungs, pleura, kidneys, spleen, adrenal glands, verte-
brae, ribs, and lymph nodes. Based on the above findings,
the tumor was diagnosed as primary pancreatic neuroen-
docrine carcinoma with systemic metastases.
Discussion
Non-functioning pancreatic endocrine carcinomas are
hormonally silent by definition. Growing large, they dis-
play symptoms attributable to local disease or distant
metastases. In autopsy series, the heart is a relatively com-
mon site for metastatic tumors, which are at least 100
times more common than primary malignant cardiac
tumors [2,3]. The incidence of cardiac metastases is on the
rise due to longer patient survival attendant upon
improved chemotherapy and radiotherapy, coupled with
increasingly sensitive diagnostic modalities. Although dif-
ficult to define, the incidence of cardiac involvement in
patients with malignant neoplasms is probably above
10% [4]. Metastases reach the heart and the pericardium
through retrograde lymphatic spread, the bloodstream,
direct invasion, or by direct venous extension. In our
present case, myocardial metastases reflected severe lym-
phatic invasion of tumor cells. Myocardial metastases
directly from neuroendocrine carcinoma are rare, with a
reported incidence of 2% to 4%, and usually found in
patients with widespread metastatic disease and extensive
liver infiltration [5,6]. Interestingly, a similar case of myo-
cardial metastasis from pancreatic carcinoma (specific his-
tology unknown) presenting as acute myocardial
infarction was reported [7]. Myocardial metastases may
cause an unexpected cardiac manifestation.
Macroscopic findings of the pancreas Figure 1
Macroscopic findings of the pancreas. A: pancreas, 
weighing 400 g, was occupied by the tumor. B: on the cut 
surface, residual pancreatic tissue was not macroscopically 
identifiable.
Microscopic findings of the tumor Figure 2
Microscopic findings of the tumor. A: the tumor cells 
showed nested or trabecular architecture suggesting neu-
roendocrine differentiation. B, C and D: tumor cells were 
positive for neuroendocrine markers (synaptophysin (B), 
NCAM (CD56) (C), and chromogranin A (D)).Cases Journal 2009, 2:9127 http://www.casesjournal.com/content/2/1/9127
Page 3 of 3
(page number not for citation purposes)
In conclusion, a rare autopsy case of non-functioning pan-
creatic neuroendocrine carcinoma metastasizing to myo-
cardium and mimicking hypertrophic cardiomyopathy is
reported.
Consent
Written informed consent was obtained from the patient
for the publication of this case report with accompanying
images. A copy of the written consent is available for
reviewing by the Editor-in-Chief of the journal.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors analyzed and interpreted the autopsy data. RK
and SK performed autopsy and histological examinations.
EK and KM assisted with the histological examinations.
TK is the major contributor to the writing of the manu-
script. SK supported the case analysis and the writing of
the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We thank Miki Zenigami-Yamazaki, Noriko Sakamoto, and Shuichi Matsuda 
at Kobe University for their excellent technical assistance, and Dr. Junko 
Ishii at Kobe City Medical Center General Hospital for helpful discussions.
References
1. O'Grady HL, Conlon KC: Pancreatic neuroendocrine tumours.
Eur J Surg Oncol 2008, 34:324-332.
2. Hanfling SM: Metastatic cancer to the heart. Review of the lit-
erature and report of 127 cases.  Circulation 1960, 22:474-483.
3. Schoen FJ, Berger BM, Guerina NG: Cardiac effects of noncardiac
neoplasms.  Cardiol Clin 1984, 2:657-670.
4. Klatt EC, Heitz DR: Cardiac metastases.  Cancer 1990,
65:1456-1459.
5. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot
HC, Kvols LK: Carcinoid heart disease. Clinical and echocardi-
ographic spectrum in 74 patients.  Circulation 1993,
87:1118-1196.
6. Pandya UH, Pellikka PA, Enriquez-Sarano M, Edwards WD, Schaff HV,
Connolly HM: Metastatic carcinoid tumor to the heart:
echocardiographic-pathologic study of 11 patients.  J Am Coll
Cardiol 2002, 40:1328-1332.
7. Robinson BW, Lewis RR: Myocardial metastasis from carci-
noma of pancreas presenting as acute myocardial infarction.
J R Soc Med 1982, 75:560-562.
Macroscopic and microscopic findings of the heart Figure 3
Macroscopic and microscopic findings of the heart. A: cut surface of the heart. The heart weighed 780 g and showed 
numerous metastatic nodules and diffuse myocardial thickening, simulating hypertrophic cardiomyopathy. B: metastatic tumor 
cells invaded the myocardium with stromal edema (HE). C: immunohistochemical analysis for D2-40 demonstrated severe lym-
phatic infiltration of tumor cells.